US Stock Fluctuation: Legend Biotech surged on October 14th due to CARVYKTI sales
Bitget异动解读2026/10/14 17:35Legend Biotech October 14 Surge Analysis
Keywords: CARVYKTI sales
For the quarter ended September 30, 2026, the preliminary net trade sales of CARVYKTI, a collaboration between Legend Biotech and Janssen, amounted to approximately $710 million; this data is based on information provided by Janssen and has not been independently verified by either party.
(Disclaimer: This content is a summary generated by AI technology from publicly available information and is for reference only; it does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stocks move: Erasca plunges on October 16 due to a high-level correction
U.S. natural gas futures decline as mild weather and demand expectations weigh
Crypto prices
More
